Gapping up
In reaction to earnings/guidance:
- ATEN +9.7%, TEAM +9.1%, VCRA +8.7%, X +8.3% (also $300 mln stock repurchase program; increases dividend), SM +6.3%, RILY +6.2%, NATI +4.7%, HUN +4.4%, RMD +4.3%, WETF +4.2%, ACHC +3.6%, PSX +3.5%, AVT +3.2%, PSXP +3.2%, CWST +3.1%, HLI +3%, MERC +2.6%, NXGN +2.5% (also authorizes $60 mln stock repurchase plan), PTCT +2.4%, NWL +2.4%, OPK +2.2%, SKX +2.2%, SKYW +1.9%, B +1.8%, AX +1.7%, TFII +1.6%, BIO +1.4%, SGEN +1.2%, HIG +1%, ASPN +0.9%, XOM +0.9%, MSTR +0.8%
Other news:
- XELA +9.9% (partners with CareSource)
- OYST +6.3% (Point72 discloses 8.8% passive stake)
- PLXP +4.5% (provides VAZALORE launch update - launch in line with expectations and exceptionally positive feedback from consumers)
- TWNT +2.6% (to combine with Terran Orbital)
- IMMP +1.7% (receives positive EMA scientific advice for further clinical development of efti in MBC including Phase III)
- NEU +1.5% (approves new $500 mln share repurchase program)
- BCC +1.1% (increases dividend) .
Analyst comments:
- RPRX +2.3% (upgraded to Buy from Neutral at Citigroup)
- AYX +2.2% (upgraded to Neutral from Underweight at JP Morgan)
- BC +1.7% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)
- CHKP +1.5% (upgraded to Buy from Hold at Deutsche Bank)
- CAT +1.3% (upgraded to Buy from Neutral at UBS)